GMP-Manufacturing Services Agreement by and between Variation Biotechnologies, Inc. and Paragon Bioservices, Inc.GMP-Manufacturing Services Agreement • February 5th, 2016 • SciVac Therapeutics Inc. • Gold and silver ores • Maryland
This GMP-Manufacturing Services Agreement (this “Agreement” or “GMP-MSA”) is effective as of September 26, 2014 (the “Effective Date”), by and between Variation Biotechnologies, Inc., federally incorporated in Canada and having its principal office at 310 Hunt Club Rd. East, 2nd Floor, Ottawa, ON, Canada, K1V 1C1 (“Client”) and Paragon Bioservices, Inc., a Maryland corporation having its principal office at University of Maryland Biopark, Building Two, Suite 401, 801 W. Baltimore Street, Baltimore, MD 21201 (“Paragon”) (each, a “Party” and together the “Parties”).
